Literature DB >> 76018

Transmission of non-A, non-B hepatitis from man to chimpanzee.

E Tabor, R J Gerety, J A Drucker, L B Seeff, J H Hoofnagle, D R Jackson, M April, L F Barker, G Pineda-Tamondong.   

Abstract

Non-A, non-B hepatitis was transmitted to four colony-born chimpanzees by intravenous inoculation of human sera. Two chimpanzees were inoculated with serum from a patient with a clinical and serological diagnosis of chronic non-A, non-B hepatitis whose blood appeared to transmit this disease to a nurse following accidental needle-stick, and the other two chimpanzees were inoculated with serum from either of two former blood-donors whose HBsAg-negative blood appeared to transmit clinically recognisable hepatitis, and who were found to have raised serum-aminotransferase levels 1 1/2 and 5 years later. Serum-aminotransferase levels rose in all four chimpanzees, beginning 2--4 weeks after inoculation: peak alanine-aminotransferase values were 210 to 328 I.U./l. Evidence of hepatitis was present in liver biopsy specimens from all four chimpanzees, beginning 8--10 weeks after inoculation. None showed serological evidence of infection with hepatitis A virus, hepatitis B virus, cytomegalovirus, or Epstein-Barr virus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 76018     DOI: 10.1016/s0140-6736(78)90132-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  43 in total

1.  A transgenic mouse model of steatosis and hepatocellular carcinoma associated with chronic hepatitis C virus infection in humans.

Authors:  S M Lemon; H Lerat; S A Weinman; M Honda
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

Review 2.  Non-A, non-B hepatitis.

Authors:  T N Dewar
Journal:  West J Med       Date:  1990-08

Review 3.  Viruses and human cancer: from detection to causality.

Authors:  Ronit Sarid; Shou-Jiang Gao
Journal:  Cancer Lett       Date:  2010-10-23       Impact factor: 8.679

4.  Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity.

Authors:  A J Weiner; X Paliard; M J Selby; A Medina-Selby; D Coit; S Nguyen; J Kansopon; C L Arian; P Ng; J Tucker; C T Lee; N K Polakos; J Han; S Wong; H H Lu; S Rosenberg; K M Brasky; D Chien; G Kuo; M Houghton
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Immune response to purified non-A, non-B hepatitis-related antigen demonstrated by leukocyte migration inhibition in patients recovering from the infection.

Authors:  A Nicole; O Spertini; D Lavanchy; P C Frei
Journal:  Infection       Date:  1986 Jan-Feb       Impact factor: 3.553

Review 6.  Current testing strategies for hepatitis C virus infection in blood donors and the way forward.

Authors:  Neelam Marwaha; Suchet Sachdev
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

Review 7.  Adaptive immunity to the hepatitis C virus.

Authors:  Christopher M Walker
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

Review 8.  The hazards of blood transfusion in historical perspective.

Authors:  Harvey J Alter; Harvey G Klein
Journal:  Blood       Date:  2008-10-01       Impact factor: 22.113

Review 9.  Epidemiology of chronic viral hepatitis in the Mediterranean area: present status and trends.

Authors:  G B Gaeta; G Giusti
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

Review 10.  Mortality and morbidity among military personnel and civilians during the 1930s and World War II from transmission of hepatitis during yellow fever vaccination: systematic review.

Authors:  Roger E Thomas; Diane L Lorenzetti; Wendy Spragins
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.